ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 148

Chronic Fatigue Symptoms in Children with Abrupt Early-onset OCD And/or PANS

Avis Chan 1, Angeline Truong 2, Bahare Farhadian 3, Theresa Willett 2, Melissa Silverman 1, Paula Tran 1, Margo Thienemann 2 and Jennifer Frankovich4, 1Stanford University School of Medicine, Palo Alto, 2Stanford University School of Medicine, Palo Alto, California, 3Stanford Immune Behavioral Health Clinic and PANS Research Program at Lucile Packard Children's Hospital, Palo Alto, 4Stanford

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Chronic fatigue syndrome, Fatigue, Myalgic encephalomyelitis, Obsessive compulsive disorder, PANS

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Saturday, May 2, 2020

Title: Poster Session 3

Session Type: ACR Abstract Session

Session Time: 4:15PM-5:15PM

Background/Purpose: Chronic Fatigue Syndrome (CFS)/Myalgic encephalomyelitis (ME) affects roughly 2.5 million people in the United States, and is challenging both in diagnosis and treatment. Many case definitions have been used in reporting the prevalence of CFS/ME in children and adolescents. Criteria in common include post-exertional malaise, a prolonged period of unexplained fatigue or unrefreshing sleep, pain, and autonomic manifestations. These features may overlap with some psychiatric symptoms, e.g., depression and pain amplification, which are also commonly seen in children with abrupt early-onset obsessive compulsive disorder (AEO-OCD). We define AEO-OCD as sudden-onset OCD which develops to full symptom severity within 72 hours in childhood, and is diagnosed by a psychiatrist. Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is characterized by AEO-OCD and/or severe eating restriction plus additional neuropsychiatric symptoms. To date, no studies have described the prevalence of chronic fatigue symptoms in children with AEO-OCD and/or PANS.

Methods: We performed a retrospective cohort study of patients evaluated at the PANS clinic between September 2012 and June 2019. We included patients meeting our definition of AEO-OCD, and excluded some cases (Fig.1). Data were drawn from patient questionnaires which caregivers and patients fill out before each clinic visit. The questionnaire queries symptoms including exercise intolerance, post exertional malaise, daytime fatigue, waking unrefreshed, cognitive symptoms, and psychometric scale ratings for their psychiatric symptoms. Missing data on questionnaires were replaced by data closest to the visit occurring within ten days of the missing data. We also reviewed charts to supplement data on exercise intolerance. We reported numbers/proportions of patients meeting CFS symptoms and the 2015 Institute of Medicine (IOM) diagnostic criteria for CFS/ME which require more than six months of fatigue, moderate or severe problems with waking unrefreshed, moderate or severe cognitive problems, and exercise intolerance. Kaplan Meier curve was used to determine the time-dependent risk of developing CFS/ME in our sample. Patients were censored at their last follow-up.

Results: Our study cohort was comprised of 188 patients: mean (SD) age of OCD onset was 8.7 (8.3) years; 115 (61%) were male and 152 (81%) were White. Table 1 shows the number of patients who reported different chronic fatigue symptoms. Using the 2015 IOM criteria, 32 (17%) patients in our sample were diagnosed with CFS/ME. From the Kaplan Meier curve, the median time to diagnosis of CFS/ME was 5.8 (95% CI, 5.6-6.1) years in clinic (Fig.2).

Conclusion: Our study shows that CFS/ME occurs in 1 in 6 patients with AEO-OCD. The prevalence rate is much higher than the general adolescent population (1 in 100-200). This underscores the need to systematically assess fatigue in this group of patients. Future studies should determine possible shared biological underpinnings between AEO-OCD/PANS and CFS/ME.

Figure 1. Inclusion and exclusion flowchart for this study.

Figure 2. Kaplan_Meier curve showing the time_dependent risk of developing chronic fatigue syndrome/myalgic encephalomyelitis based on the 2015 Institute of Medicine (IOM) diagnostic criteria.

Table 1. Demographic and clinical characteristics of 188 consecutive patients meeting the study criteria.


Disclosure: A. Chan, None; A. Truong, None; B. Farhadian, None; T. Willett, None; M. Silverman, None; P. Tran, None; M. Thienemann, None; J. Frankovich, None.

To cite this abstract in AMA style:

Chan A, Truong A, Farhadian B, Willett T, Silverman M, Tran P, Thienemann M, Frankovich J. Chronic Fatigue Symptoms in Children with Abrupt Early-onset OCD And/or PANS [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/chronic-fatigue-symptoms-in-children-with-abrupt-early-onset-ocd-and-or-pans/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chronic-fatigue-symptoms-in-children-with-abrupt-early-onset-ocd-and-or-pans/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology